Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (3): 209-217.DOI: 10.3969/j.issn.1673-8640.2025.03.002
Previous Articles Next Articles
LI Hanhua, WU Yazhou, WENG Wenhao(
)
Received:2024-05-16
Revised:2024-09-25
Online:2025-03-30
Published:2025-04-10
CLC Number:
LI Hanhua, WU Yazhou, WENG Wenhao. Status of laboratory testing for autoimmune encephalitis-related antibodies[J]. Laboratory Medicine, 2025, 40(3): 209-217.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.03.002
| 项目 | 推荐 方法 | 筛查 方法 | 确认 方法 |
|---|---|---|---|
| ANNA-1(抗Hu抗体) | LIA | IFA | LIA |
| ANNA-2(抗Ri抗体) | LIA | IFA | LIA |
| 抗PCA-1抗体(抗Yo抗体) | LIA | IFA | LIA |
| 抗PNMA2抗体(抗Ma2抗体) | LIA | IFA | LIA |
| 抗CV2/CRMP5①抗体 | LIA | IFA | LIA |
| 抗amphiphysin②抗体 | LIA | IFA | LIA |
| 抗 GAD抗体 | ELISA/LIA | IFA | ELISA/LIA |
| 抗神经元表面抗原抗体 | IFA | ||
| 抗NMDAR抗体 | IFA |
| 项目 | 推荐 方法 | 筛查 方法 | 确认 方法 |
|---|---|---|---|
| ANNA-1(抗Hu抗体) | LIA | IFA | LIA |
| ANNA-2(抗Ri抗体) | LIA | IFA | LIA |
| 抗PCA-1抗体(抗Yo抗体) | LIA | IFA | LIA |
| 抗PNMA2抗体(抗Ma2抗体) | LIA | IFA | LIA |
| 抗CV2/CRMP5①抗体 | LIA | IFA | LIA |
| 抗amphiphysin②抗体 | LIA | IFA | LIA |
| 抗 GAD抗体 | ELISA/LIA | IFA | ELISA/LIA |
| 抗神经元表面抗原抗体 | IFA | ||
| 抗NMDAR抗体 | IFA |
| [1] | HAYDEN Z, BÓNÉ B, ORSI G, et al. Clinical characteristics and outcome of neuronal surface antibody-mediated autoimmune encephalitis patients in a national cohort[J]. Front Neurol, 2021, 12:611597. |
| [2] |
DALMAU J, TÜZÜN E, WU H Y, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61(1):25-36.
DOI PMID |
| [3] |
DUBEY D, PITTOCK S J, KELLY C R, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis[J]. Ann Neurol, 2018, 83(1):166-177.
DOI PMID |
| [4] | ERICKSON T A, MUSCAL E, MUNOZ F M, et al. Infectious and autoimmune causes of encephalitis in children[J]. Pediatrics, 2020, 145(6):e20192543. |
| [5] | BOESEN M S, BORN A P, LYDOLPH M C, et al. Pediatric autoimmune encephalitis in Denmark during 2011-17:a nationwide multicenter population-based cohort study[J]. Eur J Paediatr Neurol, 2019, 23(4):639-652. |
| [6] | NAGIREDDY R B R, KUMAR A, SINGH V K, et al. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder(NMOSD)and MOG antibody associated disease(MOGAD):a prospective observational study and review of literature[J]. J Neuroimmunol, 2021, 361:577742. |
| [7] | SWAYNE A, WARREN N, PRAIN K, et al. An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation,investigation results,and response to therapy[J]. Front Neurol, 2021, 12:607773. |
| [8] | YASUMOTO R, KAWANO M, TSUJINO T, et al. Seminal plasma cytokines in nonbacterial prostatitis:changes following sparfloxacin treatment[J]. Hinyokika Kiyo, 1995, 41(10):771-774. |
| [9] | HÉBERT J, MUCCILLI A, WENNBERG R A, et al. Autoimmune encephalitis and autoantibodies:a review of clinical implications[J]. J Appl Lab Med, 2022, 7(1):81-98. |
| [10] | ABDEL AZIZ K, STIP E, ARNONE D. More than just anti-NMDAR:the many facets of autoimmune encephalitis[J]. BJPsych Bull, 2021, 46(4):1-5. |
| [11] | RÖSSLING R, PRÜSS H. SOP:antibody-associated autoimmune encephalitis[J]. Neurol Res Pract, 2020, 2:1. |
| [12] | NILSSON A C, NISSEN M S, RYDING M, et al. Autoimmune encephalitis[J]. Ugeskr Laeger, 2021, 183(25):V01210018. |
| [13] |
YE F, FAN C, PENG M, et al. Anti-IgLON5 disease in a pediatric patient with Langerhans cell histiocytosis[J]. Clin Chim Acta, 2021, 521:212-214.
DOI PMID |
| [14] | GRAUS F, DELATTRE J Y, ANTOINE J C, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes[J]. J Neurol Neurosurg Psychiatry, 2004, 75(8):1135-1140. |
| [15] | PROBST C, SASCHENBRECKER S, STOECKER W, et al. Anti-neuronal autoantibodies:current diagnostic challenges[J]. Mult Scler Relat Disord, 2014, 3(3):303-320. |
| [16] |
GRAUS F, TITULAER M J, BALU R, et al. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15(4):391-404.
DOI PMID |
| [17] | HACOHEN Y, WRIGHT S, WATERS P, et al. Paediatric autoimmune encephalopathies:clinical features,laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens[J]. J Neurol Neurosurg Psychiatry, 2013, 84(7):748-755. |
| [18] | GASTALDI M, MARIOTTO S, GIANNOCCARO M P, et al. Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis:a multicenter retrospective study[J]. Eur J Neurol, 2020, 27(4):633-643. |
| [19] | ALAMOWITCH S, GRAUS F, UCHUYA M, et al. Limbic encephalitis and small cell lung cancer. Clinical and immunological features[J]. Brain, 1997, 120(Pt 6):923-928. |
| [20] | DALMAU J, GRAUS F. Diagnostic criteria for autoimmune encephalitis:utility and pitfalls for antibody-negative disease[J]. Lancet Neurol, 2023, 22(6):529-540. |
| [21] | HARA M, MARTINEZ-HERNANDEZ E, ARIÑO H, et al. Clinical and pathogenic significance of IgG,IgA,and IgM antibodies against the NMDA receptor[J]. Neurology, 2018, 90(16):e1386-e1394. |
| [22] | UY C E, BINKS S, IRANI S R. Autoimmune encephalitis:clinical spectrum and management[J]. Pract Neurol, 2021, 21(5):412-423. |
| [23] | MATTAR A, HONNORAT J, JOUBERT B. Autoimmune encephalitis:an update[J]. Rev Prat, 2022, 72(1):85-90. |
| [24] |
LAI M, HUGHES E G, PENG X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location[J]. Ann Neurol, 2009, 65(4):424-434.
DOI PMID |
| [25] | UY C E, MAYXAY M, HARRISON R, et al. Detection and significance of neuronal autoantibodies in patients with meningoencephalitis in Vientiane,Lao PDR[J]. Trans R Soc Trop Med Hyg, 2022, 116(10):959-965. |
| [26] | VAN COEVORDEN-HAMEETE M H, DE GRAAFF E, TITULAER M J, et al. Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system[J]. Autoimmun Rev, 2014, 13(3):299-312. |
| [27] | ABBOUD H, PROBASCO J, IRANI S R, et al. Autoimmune encephalitis:proposed recommendations for symptomatic and long-term management[J]. J Neurol Neurosurg Psychiatry, 2021, 92(8):897-907. |
| [28] | KAO Y C, LIN M I, WENG W C, et al. Neuropsychiatric disorders due to limbic encephalitis:immunologic aspect[J]. Int J Mol Sci, 2020, 22(1):389. |
| [29] | LIM J A, LEE S T, MOON J, et al. Development of the clinical assessment scale in autoimmune encephalitis[J]. Ann Neurol, 2019, 85(3):352-358. |
| [30] | DALMAU J, GRAUS F, VILLAREJO A, et al. Clinical analysis of anti-Ma2-associated encephalitis[J]. Brain, 2004, 127(8):1831-1844. |
| [31] | 中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版)[J]. 中华神经科杂志, 2022, 55(9):931-949. |
| [32] | TOSHIDA K, TOSHIMA T, ITOH S, et al. Caution to poor adherence with immunosuppressant medication that causes coma-onset autoimmune encephalitis:a case report and literature review[J]. Transplant Proc, 2023, 55(8):1968-1971. |
| [33] | 中国免疫学会临床免疫分会专家组. 自身免疫病诊断中抗体检测方法的推荐意见[J]. 中华检验医学杂志, 2020,(9):878-888. |
| [34] | ZHANG S, MAO C, LI X, et al. Advances in potential cerebrospinal fluid biomarkers for autoimmune encephalitis:a review[J]. Front Neurol, 2022, 13:746653. |
| [35] | ZHANG Y, LIAN B, YANG S, et al. Metabotropic glutamate receptor 5-related autoimmune encephalitis with reversible splenial lesion syndrome following SARS-CoV-2 vaccination[J]. Medicine(Baltimore), 2023, 102(7):e32971. |
| [36] | LIANG C, CHU E, KUOY E, et al. Autoimmune-mediated encephalitis and mimics:a neuroimaging review[J]. J Neuroimaging, 2023, 33(1):19-34. |
| [37] | REN H, FAN S, ZHAO Y, et al. The changing spectrum of antibody-mediated encephalitis in China[J]. J Neuroimmunol, 2021, 361:577753. |
| [38] | DONG X, ZHENG D, NAO J. Circulating exosome microRNAs as diagnostic biomarkers of dementia[J]. Front Aging Neurosci, 2020, 12:580199. |
| [39] | HUANG J C, SCHLEISMAN M, CHOI D, et al. Preliminary report on interleukin-22,GM-CSF,and IL-17F in the pathogenesis of acute anterior uveitis[J]. Ocul Immunol Inflamm, 2021, 29(3):558-565. |
| [40] |
THOMPSON E N, CARLINO M J, SCANLON V M, et al. Assay optimization for the objective quantification of human multilineage colony-forming units[J]. Exp Hematol, 2023, 124:36-44.
DOI PMID |
| [41] | ROCCA M A, CACCIAGUERRA L, FILIPPI M. Moving beyond anti-aquaporin-4 antibodies:emerging biomarkers in the spectrum of neuromyelitis optica[J]. Expert Rev Neurother, 2020, 20(6):601-618. |
| [42] | ZHANG F, GAO X, LIU J, et al. Biomarkers in autoimmune diseases of the central nervous system[J]. Front Immunol, 2023, 14:1111719. |
| [43] | MA Y, SU H, YUKSEL M, et al. Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of European ancestry[J]. Hepatology, 2021, 74(4):2032-2046. |
| [44] | SHAHI S K, ALI S, JAIME C M, et al. HLA classⅡpolymorphisms modulate gut microbiota and experimental autoimmune encephalomyelitis phenotype[J]. Immunohorizons, 2021, 5(8):627-646. |
| [45] | VOGRIG A, MUNIZ-CASTRILLO S, DESESTRET V, et al. Pathophysiology of paraneoplastic and autoimmune encephalitis:genes,infections,and checkpoint inhibitors[J]. Ther Adv Neurol Disord, 2020, 13:1756286420932797. |
| [46] | BARRIOS-MENENDEZ J C, CARIAS-ALVARADO C C, CAYAX L I, et al. HLA-DRB1 and HLA-DQB1 genes in patients diagnosed with systemic lupus erythematosus in Guatemala[J]. Hum Immunol, 2024, 85(3):110803. |
| [47] | COSTA D, SARDOEIRA A, CARNEIRO P, et al. Autoimmune encephalitis:suspicion in clinical practice and mimics[J]. J Neuroimmunol, 2022, 365:577824. |
| [48] | DINOTO A, ZARA P, MARIOTTO S, et al. Autoimmune encephalitis misdiagnosis and mimics[J]. J Neuroimmunol, 2023, 378:578071. |
| [49] | BORDONNE M, CHAWKI M B, DOYEN M, et al. Brain(18)F-FDG PET for the diagnosis of autoimmune encephalitis:a systematic review and a meta-analysis[J]. Eur J Nucl Med Mol Imaging, 2021, 48(12):3847-3858. |
| [50] | RAO S, NETRAVATHI M, MAHADEVAN A. Role of the pathologist in the diagnosis of autoimmune encephalitis[J]. Indian J Pathol Microbiol, 2022, 65(Supplement):S198-S206. |
| [51] | HE J, LIAN Y. Clinical study of autonomic dysfunction in patients with autoimmune encephalitis[J]. Immunobiology, 2023, 228(5):152711. |
| [52] | BAUER A, RUDZKI D, BEREK K, et al. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder[J]. Front Immunol, 2022, 13:1037812. |
| [53] | SHIMIZU F, TAKESHITA Y, HAMAMOTO Y, et al. GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica[J]. Ann Clin Transl Neurol, 2019, 6(10):2079-2087. |
| [54] | SOOKSAWASDI NA AYUDHYA S, SIPS G J, BOGERS S, et al. Detection of intrathecal antibodies to diagnose enterovirus infections of the central nervous system[J]. J Clin Virol, 2022, 152:105190. |
| [55] | COWAN R P, GROSS N B, SWEENEY M D, et al. Evidence that blood-CSF barrier transport,but not inflammatory biomarkers,change in migraine,while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen[J]. Headache, 2021, 61(3):536-545. |
| [56] | CELLUCCI T, VAN MATER H, GRAUS F, et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(2):663. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||